4.7 Article

Food allergy: Update on prevention and tolerance

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 141, Issue 1, Pages 30-40

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2017.11.010

Keywords

Food allergy; peanut allergy; egg allergy; allergy prevention

Funding

  1. National Institute of Allergy and Infectious Diseases (NIAID, NIH)
  2. Food Allergy & Research Education (FARE)
  3. MRC & Asthma UK Centre
  4. UK Department of Health through NIHR
  5. National Peanut Board (NPB)
  6. UK Food Standards Agency (FSA)
  7. National Institute of Allergy and Infectious Diseases [AI-44236]
  8. NIH AITC Review Panel
  9. Allertein
  10. American Society for Microbiology
  11. Elsevier
  12. FARE
  13. World Allergy Organization
  14. Adept Field Solutions
  15. Aimmune Therapeutics, Inc
  16. Astellas Pharma Global Development, Inc
  17. Biomerica, Inc
  18. Evelo Biosciences, Inc/Epiva Biosciences, Inc
  19. First Manhattan Co
  20. Genentech
  21. GLG Research, Inc
  22. Insys Therapeutics
  23. Intrommune Therapeutics
  24. PPD Development, LP
  25. Regeneron Pharmceuticals, Inc
  26. Sanofi US Services
  27. SRA International
  28. Stallergenes
  29. UKKO, Inc
  30. Valeant Pharmaceuticals North America, LLC
  31. Food Allergy Research and Education (FARE)
  32. National Institutes of Health
  33. Wallace Research Foundation
  34. Actellion
  35. European Union project Medall
  36. Allergopharma
  37. Swiss National Science Foundation
  38. Christine Kuhne Center for Allergy Research and Education
  39. National Institutes of Allergy and Infectious Diseases [NO1-AI-15416, UM1AI109565]
  40. UK Department of Health through the National Institute for Health Research
  41. National Peanut Board
  42. Osem
  43. European Union project Predicta

Ask authors/readers for more resources

Of the many possible hypotheses that explain the recent increase in childhood food allergy (FA), the dual-allergen exposure hypothesis has been the most extensively investigated. This chapter serves as a review and update on the prevention of FA and focuses on recently published randomized controlled trials exploring the efficacy of oral tolerance induction in infancy for the prevention of FA. As a result of these RCTs, National Institutes of Health recommendations now actively encourage the early introduction of peanut for the prevention of peanut allergy, and other countries/settings recommend the inclusion of potential common food allergens, including peanut and egg, in complementary feeding regimens commencing at approximately 6 months but not before 4 months of age. Further studies that explore the efficacy of oral tolerance induction to other common food allergens and that focus on optimal timing, duration, and adherence are required.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available